• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, August 23, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

New Hope in Fight Against Aggressive, Often Hard to Treat Brain Tumor

Bioengineer by Bioengineer
September 25, 2016
in Cancer
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Researchers from the University of Southampton have discovered a potential way of stopping one of the most aggressive types of brain tumor from spreading, which could lead the way to better patient survival.

Credit: Dailyecho.co.uk
Credit: Dailyecho.co.uk

Glioblastoma is one of the most common types of malignant brain tumors in adults. They are fast growing and can spread easily. The tumor has threadlike tendrils that extend into other parts of the brain making it difficult to remove it all.

Although there have been great advances made in the treatment of leukemias and other cancers, little is known about how Glioblastomas are formed and how these tumors infiltrate the brain tissue.

Published in Molecular Neurobiology, the study led by Dr Elodie Siney under the supervision of Dr Sandrine Willaime-Morawek, Lecturer in Stem Cells and Brain Repair at the University, analysed how enzymes called ADAMs affect the movement and function of the human tumor cells.

The findings suggest that if you are able to block specific enzymes called ADAM10 and ADAM17 the tumor stops growing and spreading. It also moves the cancer cells away from the place where they were growing which could allow them to be removed through traditional cancer treatments such as radiotherapy, chemotherapy or surgery.

“When confirmed in animal models of glioblastoma, this finding will be of great importance for patients and clinicians,” said Sandrine. “Glioblastoma is a devastating disease which is often untreatable. We have found that blocking ADAMs may lead to reduced tumor growth and less recurrence following conventional treatments, improving the chance of complete surgical removal and improving survival rates.”

Web Source: University of Southampton.

Reference List:

Elodie J. Siney, Alexander Holden, Elizabeth Casselden, Harry Bulstrode, Gareth J. Thomas, Sandrine Willaime-Morawek. Metalloproteinases ADAM10 and ADAM17 Mediate Migration and Differentiation in Glioblastoma Sphere-Forming Cells. Molecular Neurobiology, 2016; DOI: 10.1007/s12035-016-0053-6

The post New Hope in Fight Against Aggressive, Often Hard to Treat Brain Tumor appeared first on Scienmag.

Share12Tweet8Share2ShareShareShare2

Related Posts

Dual-oxygen pancreatic cancer organoids mirror basal-classical diversity, spatial transcriptomics confirms

Dual-oxygen pancreatic cancer organoids mirror basal-classical diversity, spatial transcriptomics confirms

August 23, 2026

Consensus Roadmap Guides Clinical Trials for Rare Childhood CNS Tumors

August 22, 2026

Blood-camouflaged liquid metal nanoparticles combat aggressive breast cancer

August 22, 2026

GPR52’s Role in Breast Cancer Cell Organization and Collective Invasion

August 22, 2026
Please login to join discussion

POPULAR NEWS

  • KAIST Surface Defects Boost Droplet Formation, Removal, and Heat Transfer by 5.5-Fold

    29 shares
    Share 12 Tweet 7
  • Dual-oxygen pancreatic cancer organoids mirror basal-classical diversity, spatial transcriptomics confirms

    29 shares
    Share 12 Tweet 7
  • Tirzepatide Versus GLP-1 Agonists for Stroke Risk in Atrial Fibrillation and Diabetes

    29 shares
    Share 12 Tweet 7
  • Real-world study examines psychotic complications of subcutaneous foslevodopa/foscarbidopa infusions in 198 patients

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

KAIST Surface Defects Boost Droplet Formation, Removal, and Heat Transfer by 5.5-Fold

Dual-oxygen pancreatic cancer organoids mirror basal-classical diversity, spatial transcriptomics confirms

Tirzepatide Versus GLP-1 Agonists for Stroke Risk in Atrial Fibrillation and Diabetes

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.